×
Back to Agenda
Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology
Session Chair(s)
Suanna S. Bruinooge, MPH
Chief and Division Director, Research Strategy and Operations Center, American Society of Clinical Oncology, United States
Improving access and minimizing burdens are critical to ensuring diverse representation in clinical trials. Panelists will discuss efforts to improve patient access to oncology clinical trials through streamlined protocols and decentralized elements.
Learning Objective : Describe the impact of incorporating decentralized elements (DE) into oncology clinical trials (CTs) on data integrity, patient safety and regulatory approvals; Explain how DE elements increase patient access and recognize opportunities to implement DE; Identify ongoing barriers to implementing DE into CT protocols and solutions to address operational challenges in expanding access to care.
Speaker(s)
How Sponsors, CROs, and Sites Can Work Together
VP, Programs and Initiatives, Digital Trials and Research Alliance, United States
Meta-Analysis of Trials During COVID
Associate Professor, Fred Hutchinson Cancer Center, United States
Implementing Trials in Large Healthcare System
Associate Professor, Intermountain Medical Oncology - IMC, United States
Have an account?